<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04962815</url>
  </required_header>
  <id_info>
    <org_study_id>2021-01</org_study_id>
    <nct_id>NCT04962815</nct_id>
  </id_info>
  <brief_title>Ceribell Delirium Data Collection Study</brief_title>
  <official_title>Ceribell Delirium Data Collection Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ceribell Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ceribell Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed as a prospective, non-randomized, observational clinical study. The&#xD;
      study will collect clinical and rrEEG (Ceribell EEG) data when monitoring subjects for&#xD;
      delirium subtypes. EEG and clinical data will be collected for the development of future&#xD;
      software algorithms to assess the presence and severity of delirium.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>7 Days</target_duration>
  <primary_outcome>
    <measure>Perform Confusion Assessment Method for the ICU (CAM-ICU) assessment</measure>
    <time_frame>2 times per day, for a maximum of six (6) days</time_frame>
    <description>Research coordinator will perform and collect CAM-ICU assessment data on study subjects</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Perform Electroencephalogram (EEG) Test</measure>
    <time_frame>6-8 hours per day, for a maximum of six (6) days</time_frame>
    <description>Record and collect EEG brain waves on study subjects using Ceribell Rapid Response EEG to assess multiple time-frequency EEG features to differentiate between delirium positive and delirium negative patients.</description>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Delirium</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electroencephalogram (EEG) Test</intervention_name>
    <description>EEG test and delirium assessments will be performed on subjects experiencing delirium in the ICU.</description>
    <other_name>Delirium Assessments</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects who experience at least one delirious episode during their ICU stay&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: All must be present&#xD;
&#xD;
          -  Age is 18 years or older&#xD;
&#xD;
          -  Clinical suspicion of delirium or subject at risk for delirium&#xD;
&#xD;
          -  Admitted to the Intensive Care Unit (ICU)&#xD;
&#xD;
          -  Expected ICU stay is greater than one (1) day&#xD;
&#xD;
          -  Subject must be fluent in English&#xD;
&#xD;
        Exclusion Criteria: All must be absent&#xD;
&#xD;
          -  Age is younger than 18 years&#xD;
&#xD;
          -  Subjects with a primary neurological or neurosurgical condition such as stroke,&#xD;
             epilepsy, brain tumor, or witnessed seizures, Parkinson's disease, traumatic brain&#xD;
             injury, craniectomy, known severe dementia, or CNS infection&#xD;
&#xD;
          -  Active CNS substance abuse, intoxication, or withdrawal&#xD;
&#xD;
          -  Unarousable or unresponsive subjects with RASS &lt; -3&#xD;
&#xD;
          -  Subject is blind, deaf, or unable to speak or understand English&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Jose Maldonado, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Timothy Girard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kunal Sampat, MNA</last_name>
    <phone>800-436-0826</phone>
    <email>kunal@ceribell.com</email>
  </overall_contact>
  <reference>
    <citation>Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE Jr, Inouye SK, Bernard GR, Dittus RS. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004 Apr 14;291(14):1753-62.</citation>
    <PMID>15082703</PMID>
  </reference>
  <reference>
    <citation>Pandharipande P, Cotton BA, Shintani A, Thompson J, Pun BT, Morris JA Jr, Dittus R, Ely EW. Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma. 2008 Jul;65(1):34-41. doi: 10.1097/TA.0b013e31814b2c4d.</citation>
    <PMID>18580517</PMID>
  </reference>
  <reference>
    <citation>McPherson JA, Wagner CE, Boehm LM, Hall JD, Johnson DC, Miller LR, Burns KM, Thompson JL, Shintani AK, Ely EW, Pandharipande PP. Delirium in the cardiovascular ICU: exploring modifiable risk factors. Crit Care Med. 2013 Feb;41(2):405-13. doi: 10.1097/CCM.0b013e31826ab49b. Erratum in: Crit Care Med. 2013 Apr;41(4):e41. Pandhvaripande, Pratik P [corrected to Pandharipande, Pratik P].</citation>
    <PMID>23263581</PMID>
  </reference>
  <reference>
    <citation>Maldonado JR. Acute Brain Failure: Pathophysiology, Diagnosis, Management, and Sequelae of Delirium. Crit Care Clin. 2017 Jul;33(3):461-519. doi: 10.1016/j.ccc.2017.03.013. Review.</citation>
    <PMID>28601132</PMID>
  </reference>
  <reference>
    <citation>Khan BA, Perkins AJ, Gao S, Hui SL, Campbell NL, Farber MO, Chlan LL, Boustani MA. The Confusion Assessment Method for the ICU-7 Delirium Severity Scale: A Novel Delirium Severity Instrument for Use in the ICU. Crit Care Med. 2017 May;45(5):851-857. doi: 10.1097/CCM.0000000000002368.</citation>
    <PMID>28263192</PMID>
  </reference>
  <reference>
    <citation>Shenkin SD, Fox C, Godfrey M, Siddiqi N, Goodacre S, Young J, Anand A, Gray A, Hanley J, MacRaild A, Steven J, Black PL, Tieges Z, Boyd J, Stephen J, Weir CJ, MacLullich AMJ. Delirium detection in older acute medical inpatients: a multicentre prospective comparative diagnostic test accuracy study of the 4AT and the confusion assessment method. BMC Med. 2019 Jul 24;17(1):138. doi: 10.1186/s12916-019-1367-9.</citation>
    <PMID>31337404</PMID>
  </reference>
  <reference>
    <citation>Maclullich AM, Anand A, Davis DH, Jackson T, Barugh AJ, Hall RJ, Ferguson KJ, Meagher DJ, Cunningham C. New horizons in the pathogenesis, assessment and management of delirium. Age Ageing. 2013 Nov;42(6):667-74. doi: 10.1093/ageing/aft148. Epub 2013 Sep 25. Review.</citation>
    <PMID>24067500</PMID>
  </reference>
  <reference>
    <citation>Tieges Z, Evans JJ, Neufeld KJ, MacLullich AMJ. The neuropsychology of delirium: advancing the science of delirium assessment. Int J Geriatr Psychiatry. 2018 Nov;33(11):1501-1511. doi: 10.1002/gps.4711. Epub 2017 Apr 9. Review.</citation>
    <PMID>28393426</PMID>
  </reference>
  <reference>
    <citation>Ely EW, Margolin R, Francis J, May L, Truman B, Dittus R, Speroff T, Gautam S, Bernard GR, Inouye SK. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med. 2001 Jul;29(7):1370-9.</citation>
    <PMID>11445689</PMID>
  </reference>
  <reference>
    <citation>Kaplan PW. The EEG in metabolic encephalopathy and coma. J Clin Neurophysiol. 2004 Sep-Oct;21(5):307-18. Review.</citation>
    <PMID>15592005</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 29, 2021</study_first_submitted>
  <study_first_submitted_qc>July 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 15, 2021</study_first_posted>
  <last_update_submitted>July 13, 2021</last_update_submitted>
  <last_update_submitted_qc>July 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>delirium</keyword>
  <keyword>EEG</keyword>
  <keyword>Electroencephalogram</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Site investigators will have access to the participant EEG data via Ceribell EEG portal. In addition, site investigators will have access to delirium assessments conducted for study purposes.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_type>Individual Participant Data Set</doc_type>
      <doc_url>https://eeg.ceribell.com</doc_url>
      <doc_comment>This website is password protected and the de-identified individual participant data is only available to participating research sites.</doc_comment>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

